Digestive and Liver Disease Specialist, Ltd.

Norfolk, Virginia 23502

0 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease, Hepatitis C, Ulcerative Colitis

Studies at this site

• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease — Completed
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis — Completed
• Phase 3 Study of Sofosbuvir and Ribavirin — Completed